Cumulus Neuroscience to Present Data at CTAD 2023 Annual Meeting

  • Poster presentations scheduled for the 16th Clinical Trials on Alzheimer’s Disease (CTAD) Annual Meeting on Wednesday October 25th – Friday October 27th, 2023, in Boston, Massachusetts.

First published: 18th October 2023

Image of CTAD 2023 Banner

We are delighted to announce that Cumulus Neuroscience will present data at the Clinical Trials on Alzheimer’s Disease (CTAD) Annual Meeting on Wednesday October 25th – Friday October 27th in Boston, Massachusetts.

Three poster presentations have been accepted by the CTAD Scientific Program Committee, two featuring internally generated data collected from Cumulus-sponsored studies partnering with academic and clinical institutions, and one featuring data generated from a biopharma customer sponsored study.

All three poster presentations will take place on October 25th, 26th and 27th from 7:30 – 8:30 AM EST and during coffee breaks at the Boston Park Plaza:

  • Title: A real-world, longitudinal observational study in patients with Alzheimer’s Disease dementia and healthy controls, using frequent repeated digital measurements performed at-home on the Cumulus Platform: a preliminary report
  • Poster Number: 183

  • Title: Feasibility of the Cumulus electrophysiological neurocognitive platform to enable de-centralized trials in Alzheimer's Disease
  • Poster Number: 186

  • Title: Validating a novel digital cognitive platform: sensitivity to change following an alcohol challenge
  • Poster Number: 180

Back to Cumulus News